CD24 signalling through macrophage Siglec-10 is a target for cancer immunotherapy
Published 2019 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
CD24 signalling through macrophage Siglec-10 is a target for cancer immunotherapy
Authors
Keywords
-
Journal
NATURE
Volume -, Issue -, Pages -
Publisher
Springer Science and Business Media LLC
Online
2019-08-01
DOI
10.1038/s41586-019-1456-0
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Unravelling subclonal heterogeneity and aggressive disease states in TNBC through single-cell RNA-seq
- (2018) Mihriban Karaayvaz et al. Nature Communications
- Molecular Profiling of Cohorts of Tumor Samples to Guide Clinical Development of Pembrolizumab as Monotherapy
- (2018) Mark Ayers et al. CLINICAL CANCER RESEARCH
- Overview of CD24 as a new molecular marker in ovarian cancer
- (2018) Vahideh Tarhriz et al. JOURNAL OF CELLULAR PHYSIOLOGY
- CD47 Blockade by Hu5F9-G4 and Rituximab in Non-Hodgkin’s Lymphoma
- (2018) Ranjana Advani et al. NEW ENGLAND JOURNAL OF MEDICINE
- Shp1 function in myeloid cells
- (2017) Clare L. Abram et al. JOURNAL OF LEUKOCYTE BIOLOGY
- PD-1 expression by tumour-associated macrophages inhibits phagocytosis and tumour immunity
- (2017) Sydney R. Gordon et al. NATURE
- PD-1 and PD-L1 Checkpoint Signaling Inhibition for Cancer Immunotherapy: Mechanism, Combinations, and Clinical Outcome
- (2017) Hashem O. Alsaab et al. Frontiers in Pharmacology
- Pembrolizumab in Patients With Advanced Triple-Negative Breast Cancer: Phase Ib KEYNOTE-012 Study
- (2016) Rita Nanda et al. JOURNAL OF CLINICAL ONCOLOGY
- Pre-Clinical Development of a Humanized Anti-CD47 Antibody with Anti-Cancer Therapeutic Potential
- (2015) Jie Liu et al. PLoS One
- Siglec-G-CD24 axis controls the severity of graft-versus-host disease in mice
- (2014) T. Toubai et al. BLOOD
- Siglec-G/10 in self-nonself discrimination of innate and adaptive immunity
- (2014) G.-Y. Chen et al. GLYCOBIOLOGY
- Easy quantitative assessment of genome editing by sequence trace decomposition
- (2014) Eva K. Brinkman et al. NUCLEIC ACIDS RESEARCH
- Induction of Siglec-G by RNA Viruses Inhibits the Innate Immune Response by Promoting RIG-I Degradation
- (2013) Weilin Chen et al. CELL
- The CD47-signal regulatory protein alpha (SIRPa) interaction is a therapeutic target for human solid tumors
- (2012) S. B. Willingham et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Amelioration of sepsis by inhibiting sialidase-mediated disruption of the CD24-SiglecG interaction
- (2011) Guo-Yun Chen et al. NATURE BIOTECHNOLOGY
- CD47 Is an Adverse Prognostic Factor and Therapeutic Antibody Target on Human Acute Myeloid Leukemia Stem Cells
- (2009) Ravindra Majeti et al. CELL
- A novel method to determine the engulfment of apoptotic cells by macrophages using pHrodo succinimidyl ester
- (2009) Michael Miksa et al. JOURNAL OF IMMUNOLOGICAL METHODS
- CD24 and Siglec-10 Selectively Repress Tissue Damage-Induced Immune Responses
- (2009) G.-Y. Chen et al. SCIENCE
Find the ideal target journal for your manuscript
Explore over 38,000 international journals covering a vast array of academic fields.
SearchBecome a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get Started